{
  "id": 10674899,
  "title": "Swedish biotech AnaCardio raises $70.9M to advance 'safer' heart failure drug",
  "url": "https://urgent.news/2026/09/29/swedish-biotech-anacardio-raises-70-9m-to-advance-safer-heart-failure",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-29T11:00:34.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/swedish-biotech-anacardio-raises-70-9m-to-advance-safer-heart-failure-drug/"
  },
  "original_language": "en",
  "account": null,
  "summary": "AnaCardio has secured €62.5 million ($70.9 million) in a Series B fundraise to help prepare its chronic advanced heart failure drug for registrational development. The cash should give the Stockholm-based biotech a runway “well into ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}